Sie suchten nach: Methyl 2-amino-4,6-difluorobenzoate
183 results were found
Upstream processing for cell therapy
/cms/de/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Life Science Reagents
/cms/fr/tci_life_science_reagents
Life Science Reagents The life science field demands skilled scientists modern equipment and high purity reagents that produce repeatable results. Employing advanced synthesis refinement and analysis techniques TCI offers numerous world-class life...
Upstream processing for mAbs
/cms/de/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Sicherheits-Einrichtung und -Ausstattung
/cms/de/cytotoxic_equipment
Sicherheits-Einrichtung und -Ausstattung Zytotoxische Arzneimittel sind toxische chemische Substanzen die bei Kontakt schädlich für den Menschen sein können. Die Herstellung solcher Arzneimittel muss in deutlich bezeichneten separierten Räumen erf...
Upstream processing for cell therapy
/cms/fr/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Aurora Manufacturing Facility
/cms/de/aurora_manufacturing_facility
Aurora Manufacturing Facility Our 65000 sq. ft. manufacturing facility in Aurora OH USA includes a 12000 sq. ft. excipient processing center 3000 sq. ft. for repackaging 35000 sq. ft. warehouse 8000 sq. ft. office 8000 sq. ft. manufacturing area a...
Aurora Manufacturing Facility
/cms/it/aurora_manufacturing_facility
Aurora Manufacturing Facility Our 65000 sq. ft. manufacturing facility in Aurora OH USA includes a 12000 sq. ft. excipient processing center 3000 sq. ft. for repackaging 35000 sq. ft. warehouse 8000 sq. ft. office 8000 sq. ft. manufacturing area a...
Upstream processing for mAbs
/cms/it/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Herstellung von Batteriekathoden und -anoden
/cms/de/battery_cathode_anode_production
Herstellung von Batteriekathoden und -anoden Herstellung von Batteriekathoden und -anoden Avantor – Setting battery science in motion to create a better world Ein Li-Ionen-Akku hat 2 Elektroden: die Kathode und die Anode. Wenn sich die Batterie en...
Upstream processing for cell therapy
/cms/it/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Sicherheits-Einrichtung und -Ausstattung
/cms/it/cytotoxic_equipment
Sicherheits-Einrichtung und -Ausstattung Zytotoxische Arzneimittel sind toxische chemische Substanzen die bei Kontakt schädlich für den Menschen sein können. Die Herstellung solcher Arzneimittel muss in deutlich bezeichneten separierten Räumen erf...
Upstream processing for mAbs
/cms/fr/bioprocessing_mabs_upstream_processing
Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...
Aurora Manufacturing Facility
/cms/fr/aurora_manufacturing_facility
Aurora Manufacturing Facility Our 65000 sq. ft. manufacturing facility in Aurora OH USA includes a 12000 sq. ft. excipient processing center 3000 sq. ft. for repackaging 35000 sq. ft. warehouse 8000 sq. ft. office 8000 sq. ft. manufacturing area a...
Sicherheits-Einrichtung und -Ausstattung
/cms/fr/cytotoxic_equipment
Sicherheits-Einrichtung und -Ausstattung Zytotoxische Arzneimittel sind toxische chemische Substanzen die bei Kontakt schädlich für den Menschen sein können. Die Herstellung solcher Arzneimittel muss in deutlich bezeichneten separierten Räumen erf...
Upstream processing for vaccines
/cms/de/bioprocessing_vaccines_upstream_processing
Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines optimal production is achieved in mammali...
Upstream Gene Therapy Products & Solutions in Bioprocessing
/cms/fr/bioprocessing_gene_therapy_upstream_processing
Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...
65 - 80 of 183